You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
|
|---|---|
| Published in |
The Lancet, November 2005
|
| DOI | 10.1016/s0140-6736(05)67667-2 |
| Pubmed ID | |
| Authors |
A Keech, R J Simes, P Barter, J Best, R Scott, M R Taskinen, P Forder, A Pillai, T Davis, P Glasziou, P Drury, Y A Kesäniemi, D Sullivan, D Hunt, P Colman, M d'Emden, M Whiting, C Ehnholm, M Laakso |
| Abstract |
Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease, partly owing to dyslipidaemia, which can be amenable to fibrate therapy. We designed the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study to assess the effect of fenofibrate on cardiovascular disease events in these patients. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 25% |
| Colombia | 1 | 13% |
| United States | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 710 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 5 | <1% |
| Japan | 4 | <1% |
| United States | 3 | <1% |
| Australia | 2 | <1% |
| Spain | 2 | <1% |
| Canada | 2 | <1% |
| France | 1 | <1% |
| New Zealand | 1 | <1% |
| Malta | 1 | <1% |
| Other | 5 | <1% |
| Unknown | 684 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 89 | 13% |
| Student > Ph. D. Student | 88 | 12% |
| Other | 82 | 12% |
| Student > Master | 71 | 10% |
| Student > Postgraduate | 63 | 9% |
| Other | 198 | 28% |
| Unknown | 119 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 351 | 49% |
| Agricultural and Biological Sciences | 51 | 7% |
| Biochemistry, Genetics and Molecular Biology | 36 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 36 | 5% |
| Nursing and Health Professions | 16 | 2% |
| Other | 67 | 9% |
| Unknown | 153 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 61. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2023.
All research outputs
#706,725
of 26,017,215 outputs
Outputs from The Lancet
#5,984
of 43,155 outputs
Outputs of similar age
#892
of 78,786 outputs
Outputs of similar age from The Lancet
#15
of 153 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,155 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,786 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 153 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.